Medicaid is paying the lowest average price for 78 high-use and high-expenditure brand-name and generic drugs, a new federal report finds.
AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension under the Food Drug and Cosmetic Act.
Long-term care pharmacy groups propose changes to make short-cycle dispensing more efficient, cost-effectiveFebruary 05, 2013
Long-term care pharmacies are struggling with an Affordable Care Act provision related to short-cycle dispensing of brand name oral solid drugs, according to a recent letter from the Long Term Care Pharmacy Alliance and the National Community Pharmacists Association.
More than 100 medicines now appear on the government's drug shortage list. Those most often in short supply include anesthetics and oncological drugs, according to the Food & Drug Administration. Experts cite several reasons for the ongoing dearth of needed medicines.
State Medicaid programs spent $329 million more than necessary by allowing certain prescriptions for brand-name drugs to be filled instead of generics in 2009, a conservative think tank said this week.
The Medicare Part D prescription drug program saved more than $33 billion in 2007 due to the use of generic drugs, according to a new government report.